tiprankstipranks
Trending News
More News >
Nufarm Limited (AU:NUF)
ASX:NUF
Advertisement

Nufarm Limited (NUF) AI Stock Analysis

Compare
58 Followers

Top Page

AU:NUF

Nufarm Limited

(Sydney:NUF)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
AU$2.50
▲(4.60% Upside)
Nufarm Limited's overall stock score reflects a balance of financial challenges and strategic initiatives. The company's strong cash flow and strategic partnerships are positive, but declining profitability and valuation issues weigh heavily. Technical indicators suggest a bearish trend, and the earnings call highlights both opportunities and financial constraints.

Nufarm Limited (NUF) vs. iShares MSCI Australia ETF (EWA)

Nufarm Limited Business Overview & Revenue Model

Company DescriptionNufarm Limited, together with its subsidiaries, develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific. It operates through two segments, Crop Protection and Seed Technology. The company's protection solutions include herbicides, insecticides, and fungicides that help growers protect crops against weeds, pests, and diseases. It focuses on crops, such as cereals; corn; soybean; pasture, turf, and ornamentals; and trees, nuts, vines, and vegetables. It also provides seed treatment products for the protection and treatment of damage caused by insects, fungus, and disease; and distributes sunflower, sorghum, and canola seeds. Nufarm Limited was founded in 1916 and is headquartered in Laverton North, Australia.
How the Company Makes MoneyNufarm generates revenue primarily through the sale of its crop protection products, which are marketed to farmers and agricultural businesses worldwide. Key revenue streams include the sale of herbicides, insecticides, and fungicides, which are essential for pest and disease management in crops. Additionally, Nufarm earns income from its specialty products and seed technologies. The company benefits from significant partnerships with distributors, retailers, and agricultural co-operatives, which help extend its market reach. Seasonal demand fluctuations, driven by agricultural cycles and weather conditions, also play a crucial role in Nufarm's earnings, influencing the volume of products sold each year.

Nufarm Limited Earnings Call Summary

Earnings Call Date:Nov 18, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 14, 2026
Earnings Call Sentiment Neutral
The earnings call highlights a strong performance in Crop Protection and a strategic repositioning in Seed Technologies. However, significant losses from material items and challenges in the omega-3 market offset these positives. The company is focusing on debt reduction and operational improvements for future growth.
Q4-2025 Updates
Positive Updates
Strong Crop Protection Performance
Crop Protection delivered a strong result with an 18% increase in earnings and profitability growth across all regions. EBITDA margin improved by 140 basis points.
Net Debt Reduction
Net debt was reduced by $538 million from the half, ending the period with a leverage of 2.7x. This reflects strong internal discipline and efficiency.
Positive Cash Flow and Leverage Outlook
Meaningful positive cash flow and a lower CapEx profile are expected to support further leverage reduction by the end of the 2026 financial year.
Improved Revenue and Profitability in Seed Technologies
Seed Technologies showed increased revenue and profitability in South America, and progress in repositioning strategy to focus on hybrid seeds.
Negative Updates
Statutory Loss Due to Material Items
A statutory loss of $165 million was reported, including $142 million of mainly non-cash material items related to the Seed Technology review and performance improvement program.
Impact of Fish Oil Prices on Omega-3
Omega-3 earnings were impacted by a fall in fish oil prices, contributing to early-stage losses of $53 million from emerging platforms.
Challenges in Sunflower and Omega-3 Markets
Sunflower operations in Europe were scaled back due to the Russia-Ukraine conflict, leading to an impairment of sunflower IP. Omega-3 plantings in North America were also reduced due to cost considerations.
Company Guidance
During the Nufarm Limited FY '25 Results Conference Call, several key metrics and strategic directions were highlighted. The company reported a statutory loss of $165 million, influenced by $142 million in non-cash material items and a broader performance improvement program. Despite this, Crop Protection saw an 18% increase in earnings, with an EBITDA margin improvement of 140 basis points and growth across all regions. Net debt was reduced by $538 million, ending with a leverage ratio of 2.7x. The company anticipates strong EBITDA growth in FY '26, targeting a leverage of 2.0x and planning for capital expenditure below $200 million. Seed Technologies underwent a strategic review, resulting in a reprioritized strategy aimed at enhancing shareholder value, focusing on profitable hybrid seeds, a reduction in omega-3 cash requirements, and expansion in bioenergy with BP. The outlook for FY '26 includes continued growth in Crop Protection, a $30 million improvement in emerging platforms' EBITDA, and a commitment to strong cost and capital deployment discipline.

Nufarm Limited Financial Statement Overview

Summary
Nufarm Limited faces challenges with declining revenue and profitability, reflected in negative net income. However, the balance sheet shows reduced leverage and stable equity levels. The cash flow statement is a bright spot, with improved operating cash flow supporting operational resilience. Overall, while profitability remains a concern, the company's cash management and balance sheet stability provide a buffer.
Income Statement
65
Positive
Nufarm Limited has experienced fluctuating revenue with a decline in the most recent year. The gross profit margin for the latest year is approximately 25.1%, a decrease from the previous year, indicating challenges in maintaining profit levels. The net profit margin has turned negative, from 3.2% last year to -0.17% this year, highlighting profitability concerns. EBIT and EBITDA margins are unavailable for the current year due to zero EBIT, but EBITDA margin is around 7.9%, showing a decrease from prior performance.
Balance Sheet
70
Positive
The company's debt-to-equity ratio improved to 0.50 from 0.55, indicating a reduction in leverage. Return on equity has turned negative, reflecting the net loss. However, the equity ratio is stable at approximately 50%, suggesting a balanced capital structure. The improvement in net debt levels is a positive sign.
Cash Flow
75
Positive
Nufarm's operating cash flow has significantly improved, turning positive this year. The free cash flow to net income ratio is positive, indicating efficient conversion of profits into cash. However, free cash flow growth is not calculable due to negative figures in the prior year. The operating cash flow to net income ratio is strong, demonstrating robust cash generation relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.19B3.35B3.48B3.77B3.22B2.85B
Gross Profit898.59M840.37M1.03B972.59M834.71M734.73M
EBITDA181.80M263.77M427.18M421.60M359.18M-10.05M
Net Income-25.01M-5.60M111.14M107.44M65.13M-456.08M
Balance Sheet
Total Assets5.33B4.43B4.63B4.66B4.37B4.54B
Cash, Cash Equivalents and Short-Term Investments301.03M463.56M410.96M585.70M724.22M686.55M
Total Debt1.66B1.10B1.26B931.87M1.04B1.13B
Total Liabilities3.03B2.22B2.32B2.51B2.25B2.39B
Stockholders Equity2.31B2.21B2.31B2.15B2.12B2.14B
Cash Flow
Free Cash Flow77.80M219.43M-352.36M160.20M281.70M-400.42M
Operating Cash Flow220.52M472.39M-125.62M359.57M424.19M-231.51M
Investing Cash Flow-369.02M-207.46M-241.73M-240.41M-146.30M1.12B
Financing Cash Flow71.72M-200.76M185.98M-264.37M19.18M-670.68M

Nufarm Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.39
Price Trends
50DMA
2.26
Positive
100DMA
2.37
Positive
200DMA
2.82
Negative
Market Momentum
MACD
0.07
Negative
RSI
54.58
Neutral
STOCH
29.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NUF, the sentiment is Neutral. The current price of 2.39 is above the 20-day moving average (MA) of 2.33, above the 50-day MA of 2.26, and below the 200-day MA of 2.82, indicating a neutral trend. The MACD of 0.07 indicates Negative momentum. The RSI at 54.58 is Neutral, neither overbought nor oversold. The STOCH value of 29.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NUF.

Nufarm Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
$921.42M-7.32%2.91%-620.97%
48
Neutral
AU$665.13M-19.98-13.44%-267.46%
42
Neutral
AU$391.40M-9.14-90.12%-98.20%
39
Underperform
AU$1.40B-100.94-6.52%-29.27%
36
Underperform
AU$273.38M-6.62%72.45%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NUF
Nufarm Limited
2.39
-1.46
-37.92%
AU:BC8
Black Cat Syndicate Ltd.
1.06
0.31
41.33%
AU:SVM
Sovereign Metals Limited
0.52
-0.24
-31.58%
AU:GG8
Labyrinth Resources Limited
0.43
0.19
79.17%
AU:VUL
Vulcan Energy Resources Ltd.
5.13
-0.16
-3.02%
AU:PDI
Predictive Discovery Limited
0.73
0.49
204.17%

Nufarm Limited Corporate Events

Nufarm Limited Announces Quotation of New Securities
Jul 8, 2025

Nufarm Limited has announced the issuance of 60,648 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX). This move, part of an employee incentive scheme, reflects Nufarm’s ongoing efforts to align employee interests with company performance, potentially impacting its market positioning and stakeholder relations positively.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Faces Credit Rating Downgrade by S&P Global
Jun 26, 2025

Nufarm Limited has experienced a downgrade in its credit rating by S&P Global Ratings, with the long-term issuer credit rating moving from BB to BB- and its step-up securities from B to B-. This change in credit rating could impact Nufarm’s financial standing and investor confidence, potentially affecting its operations and market positioning.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Host-Plus Increases Stake in Nufarm Limited
Jun 25, 2025

Nufarm Limited has announced a change in the substantial holding of its shares by Host-Plus Pty Limited, a significant player in the superannuation industry. Host-Plus has increased its voting power from 10.30% to 11.31%, indicating a strategic move to strengthen its influence within the company. This change in shareholding may impact Nufarm’s governance and decision-making processes, potentially affecting its market positioning and stakeholder interests.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Director Increases Stake with Share Acquisition
Jun 11, 2025

Nufarm Limited announced a change in the director’s interest, with Director Adrian Percy acquiring 19,000 fully paid ordinary shares through on-market trades. This acquisition, completed on June 9 and 10, 2025, reflects a strategic move that could signal confidence in the company’s future prospects and potentially impact stakeholder perceptions positively.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Director Increases Shareholding, Signaling Confidence in Future
Jun 10, 2025

Nufarm Limited has announced a change in the director’s interest, with Frederico Tripodi acquiring an additional 6,900 fully paid ordinary shares through on-market trades over three days in June 2025. This acquisition increases Tripodi’s indirect holding to 13,270 shares, reflecting a significant personal investment in the company, which may indicate confidence in Nufarm’s future performance and strategic direction.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Director Increases Shareholding
May 30, 2025

Nufarm Limited has announced a change in the director’s interest, with David John Jones acquiring 80,000 fully paid ordinary shares through an on-market trade. This acquisition increases his direct holding to 80,000 shares, while maintaining an indirect holding of 82,000 shares. The transaction was valued at $201,792, reflecting confidence in the company’s prospects.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Director Increases Stake with Share Acquisition
May 30, 2025

Nufarm Limited announced a change in the director’s interest, with Frederico Tripodi acquiring 6,370 ordinary shares through an on-market trade. This acquisition reflects an increased personal investment in the company, potentially signaling confidence in Nufarm’s future performance and strategic direction.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Limited Announces Change in Director’s Interest
May 30, 2025

Nufarm Limited has announced a change in the director’s interest, specifically involving Lynne Saint. On May 23, 2025, Ms. Saint acquired 4,969 fully paid ordinary shares under the Nufarm Limited Non-executive Director Share Rights Plan, while an equivalent number of rights vested under the FY25 NED Plan. This change reflects the company’s ongoing commitment to aligning director interests with shareholder value, potentially impacting stakeholder perceptions and the company’s governance practices.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Limited Announces Issuance of Unquoted Equity Securities
May 30, 2025

Nufarm Limited announced the issuance and conversion of unquoted equity securities, specifically 4,969 ordinary fully paid securities, as of May 23, 2025. This move reflects the company’s ongoing financial strategies and may impact its equity structure, potentially influencing investor perception and stakeholder interests.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Limited Corrects Director’s Shareholding Disclosure
May 26, 2025

Nufarm Limited has corrected an error in its previously lodged Appendix 3Y regarding the number of ordinary shares held indirectly by Director Greg Hunt. The total number of shares was misstated as 878,813 instead of the correct total of 928,813. This correction ensures accurate reporting of the director’s interests, maintaining transparency and compliance with ASX regulations.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Limited Addresses ASX Inquiry on Earnings Consistency
May 26, 2025

Nufarm Limited has responded to an ASX inquiry regarding its earnings for the half-year ended March 31, 2025. The company clarified that its earnings information, particularly the EBITDA, did not materially differ from market expectations, remaining within 10% of analyst consensus following an adjustment to its omega 3 inventory valuation. This response highlights Nufarm’s commitment to transparency and its proactive approach in addressing market concerns, ensuring stakeholders are informed about its financial performance.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Nufarm Director Increases Stake with New Share Acquisition
May 23, 2025

Nufarm Limited has announced a change in the director’s interest, specifically involving Greg Hunt. Mr. Hunt has acquired 50,000 ordinary shares through an on-market trade, valued at $128,465.25. This acquisition reflects a strategic move to increase his indirect holdings in the company, potentially signaling confidence in Nufarm’s future performance. The transaction does not alter his direct holdings, but it does increase his indirect stake, which could have implications for stakeholder perceptions and the company’s market positioning.

The most recent analyst rating on (AU:NUF) stock is a Hold with a A$2.80 price target. To see the full list of analyst forecasts on Nufarm Limited stock, see the AU:NUF Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 08, 2025